Please Note this agenda page is still under development, and will continue to be updated.
Tuesday, May 5 – Patient Advocates
8:30–9:30 am
Location: White Flint Foyer
Registration/Continental Breakfast
9:00-10:30 am
Location: White Flint Amphitheater
Overview of Clinical Trials, Drug Development, and the Role of FDA
Panelists:
10:30am - 10:45am
Location: White Flint Foyer
BREAK
10:45-12:30 pm
Location: White Flint Amphitheater
12:30 PM - 1:30 PM
Lunch - Location: Salons G and H
1:30-3:30 pm
Location: White Flint Amphitheater
Q&A with OCE and International Regulators
Panelists:
- Marc Theoret, MD
- Paul Kluetz, MD
- Jan Brun, MSc, PhD (Health Canada, Int’l Regulator)
- Corneel Coens, MSc
Tuesday, May 5 – Scholars
12:00 PM – 5:30 PM
Location: Salon F
Lunch 12:30 PM – 1:30 PM
with patient advocates
Location: Salon F
Core Curriculum
Faculty:
- Clinical
- Nicholas Richardson, MD
- Mirat Shah, MD
- Non-clinical
- Claire Myers, PhD
- Alyssa Galaro, PhD
- Clinical Pharmacology
- Olarewanju Okusanya, PharmD, CP
- Statistics
- Jonathon Vallejo, PhD
- Somak Chatterjee, PhD
Wednesday, May 6
8:30–9:30 am
Location: Foyer D-H/ Foyer-D
Registration/Continental Breakfast
9:30-10:00 am
Location: Salons E-H
Welcome Remarks and Project 2025
10:00-12:00 pm
Location: Salons E-H
Plenary Session 1 - Global Drug Development
12:00-1:00 pm
Salon D
NETWORKING LUNCH
1:00-2:30 pm
IN-DEPTH DISCUSSION GROUP I
(Learners attend one from this list)
1:00-2:30 pm
1. AAADV 2020 Supportive and Palliative Care Discussion Session
(Patient Advocates)
Panelists:
1:00-2:30 pm
2. Repurposing drugs in oncology (International regulators)
Panelists:
1:00-2:30 pm
4. Sexual and Gender Minority in Oncology (Patient Advocates)
Panelists:
- Don Dizon, MD
- Scout, MA, PhD
- Dawn Capone, Med, LPC (Patient Advocate)
- Alison Alpert, MD
1:00-2:30 pm
5. Placeholder for hot topics and late/breaking sessions (optional)
2:30–3:00 pm
Location: Foyer D - H
Break
3:00–5:00 pm
Location: Salons E – H
Anatomy of a Drug Approval (Choose 1 to attend)
- zanubrutinib (Brukinsa, for mantle cell lymphoma)
- erdafitinib (Balversa, for FGFR-mutated urothelial cancer)
- pexidartinib (Turalio, for tenosynovial giant cell tumor)
- pembrolizumab+lenvatinib (Keytruda+Lenvima, for endometrial cancer)
5:00–7:00 pm
Location: Veranda outside; bad weather Salons E-H Foyer inside
Welcome Network Reception
Thursday, May 7th
8:30–9:30 am
Location: Salon D
Continental Breakfast
Informal Breakfast Discussion Groups for New Learners and Patient Advocates
9:30-10:30 am
Location: Salons E-H
Plenary Session 2 - Using Artificial Intelligence and Machine Learning to Inform Oncology Patient Care
Note: Audience Polling Session
Panelists:
12:30-1:30 pm
Location: Salon D
NETWORKING LUNCH
1:30-3:00 pm
IN-DEPTH DISCUSSION GROUP II
(Learners attend one from this list)
1. Learning from other diseases: HIV and Oncology (Patient Advocates)
Panelists:
2. Biosimilars (International regulators)
Panelists:
- Stacey Ricci, MEng, ScD
- Mark Fleury, PhD
- Christine Simmon, JD
- Donald Harvey, PharmD
- Bradley Scott, PhD (Health Canada, Int’l Regulator)
- Virgil Simons, MPA (Patient Advocate)
3. Oncology and the Media
Location: Salon G
Panelists:
4. Immune-Related Adverse Events: Learning from Our Mistakes and Doing Better for Our Patients
(Patient Advocates)
Panelists:
- Bianca Santomasso, MD, PhD
- Javid Moslehi, MD
- Sefanit Tesfaye (Patient Advocate)
- Donna Rivera, PharmD
- Meghan Mooradian, PhD
3:00–3:30 pm
Location: Salon D - H Foyer
Break
3:30–5:30 pm
Location: Salons E-H
Anatomy of a Drug Approval
(Choose 1 to attend)
- zanubrutinib (Brukinsa, for mantle cell lymphoma)
- erdafitinib (Balversa, for FGFR-mutated urothelial cancer)
- pexidartinib (Turalio, for tenosynovial giant cell tumor)
- pembrolizumab+lenvatinib (Keytruda+Lenvima, for endometrial cancer)
5:30–6:30 pm
Location: Veranda outside; bad weather Salons E-H Foyer inside
Network Reception
Friday, May 8th
8:30–9:30 am
Location: Salon D
Informal Breakfast Discussion Groups for New Learners and Patient Advocates Continental Breakfast
9:30-11:00 am
IN-DEPTH DISCUSSION GROUP III (Learners attend one from this list)
1. Immune-Related Adverse Events: Learning from Our Mistakes and Doing Better for Our Patients
(Patient Advocates)
Panelists:
- Bianca Santomasso, MD, PhD
- Michael Dougan, MD
- Nicole LeBoeuf, MD, MPH
- Javid Moslehi, MD
- Sefanit Tesfaye (Patient Advocate)
2. Pediatric Drug Development and FDARA
Location: Salon G
Panelists:
- Danielle Leach, MPA (Patient Advocate)
- Vivek Subbiah, MD
- Eric Ng, MD
- Victor Santana, MD
3. Biosimilars (International regulators)
Panelists:
- Stacey Ricci, MEng, ScD
- Mark Fleury, PhD
- Christine Simmon, JD
- Donald Harvey, PharmD
- Bradley Scott, PhD (Health Canada, Int’l Regulator)
- Christine Hodgdon (Patient Advocate)
4. Variant Classification and Reporting
Location: Brookside A&B
Panelists:
11:00am
Location: Salon D
AAADV Workshop Adjourn
BOX LUNCHES (TO GO)
12:00pm
Location: White Flint Amphitheater
Satellite Session
Topic: The Assessment of Value in Cancer Care